Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation: The Distinctive Natural History of Sarcomeric DCM

Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation: The Distinctive Natural History of Sarcomeric DCM

Bibliographic Details
Main Authors:	Lakdawala, N, Dellefave, L, Sparks, E, Cirino, A, Depalma, S, Funke, B, Colan, S, Watkins, H, Robinson, P, Redwood, C, Seidman, C, Seidman, J, McNally, E, Ho, C
Format:	Conference item
Published:	2009

Similar Items

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
by: Lakdawala, N, et al.
Published: (2010)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
by: Borovikov, I, et al.
Published: (2013)

Alpha-tropomyosin mutations in inherited cardiomyopathies.
by: Redwood, C, et al.
Published: (2013)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
by: Robinson, P, et al.
Published: (2007)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
by: Mirza, M, et al.
Published: (2004)

Dilated cardiomyopathy mutations in alpha-tropomyosin inhibit its movement during the ATPase cycle.
by: Borovikov, Y, et al.
Published: (2009)

Mutations in tropomyosin that cause DCM, affect cooperativity of cardiac muscle thin filaments
by: Marston, S, et al.
Published: (2007)

Two DCM mutations in cardiac tropomyosin alter thin filament function by different mechanisms
by: Marston, S, et al.
Published: (2007)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
by: Robinson, P, et al.
Published: (2007)

Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
by: Toepfer, CN, et al.
Published: (2020)

The effect of the dilated cardiomyopathy-causing mutation Glu54Lys of alpha-tropomyosin on actin-myosin interactions during the ATPase cycle.
by: Borovikov, Y, et al.
Published: (2009)

Patients with Dilated Cardiomyopathy (DCM) have appropriate myocardial oxygenation response to vasodilator stress
by: Dass Sairia, et al.
Published: (2013-01-01)

The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.
by: Mirza, M, et al.
Published: (2007)

Expression of various sarcomeric tropomyosin isoforms in equine striated muscles
by: Syamalima Dube, et al.
Published: (2017-06-01)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
by: Redwood, C, et al.
Published: (2004)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
by: Robinson, P, et al.
Published: (2007)

Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy
by: Rabia S. Khan, et al.
Published: (2022-01-01)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
by: Lorenzo Alamo, et al.
Published: (2017-06-01)

Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics
by: Daniel Mak, et al.
Published: (2021-10-01)

DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment
by: Alice Reid, et al.
Published: (2023-08-01)

Left ventricular clot: Newly known increased complication of air pollution in dilated cardiomyopathy (DCM)
by: Azin Alizadehasl, et al.
Published: (2020-09-01)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
by: Walsh, R, et al.
Published: (2017)

Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy
by: Ewa Dziewięcka, et al.
Published: (2022-02-01)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
by: Megan J. Puckelwartz, et al.
Published: (2021-04-01)

A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches
by: Vivek Sarohi, et al.
Published: (2022-06-01)

Structural and protein interaction effects of hypertrophic and dilated cardiomyopathic mutations in alpha-tropomyosin
by: Audrey N. Chang, et al.
Published: (2014-12-01)

Mutual dependence between tropomodulin and tropomyosin in the regulation of sarcomeric actin assembly in Caenorhabditis elegans striated muscle
by: Shoichiro Ono, et al.
Published: (2022-04-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin
by: Dyer, E, et al.
Published: (2007)

Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
by: Bing, W, et al.
Published: (2000)

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
by: Marston, S, et al.
Published: (2002)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
by: Carballo, S, et al.
Published: (2006)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
by: Geier, C, et al.
Published: (2008)

Effects of DCM mutations in thin filament regulatory proteins on contractile function
by: Robinson, P, et al.
Published: (2005)

Editorial: Understanding Molecular Mechanisms in Diabetic Cardiomyopathy (DCM)
by: Sakthijothi Muthu, et al.
Published: (2022-06-01)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
by: Redwood, C, et al.
Published: (2003)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Dilated cardiomyopathy and the desmin gene.
by: Mayosi, B, et al.
Published: (2000)

HCM and DCM mutations in cardiac thin filament proteins have opposite effects on the regulation of contractility in vitro
by: Redwood, C, et al.
Published: (2003)